http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1240687-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_97a285d8ecd0184a7e5d89a1e4e07997
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P41-007
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D501-32
filingDate 1968-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a24f50e4d2536a30521e2d25edc6d31c
publicationDate 1971-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1240687-A
titleOfInvention Antibacterial agents and a process for the preparation thereof
abstract 1,240,687. Cephalosporin compounds; pharmaceutical compositions; glycines. BRISTOLMYERS CO. 5 Sept., 1968 [5 Sept., 1967 (3)], No. 42345/68. Headings C2A and C2C. Novel cephalosporin compounds of the general formula and wherein R<SP>1</SP> is H or acetoxy and R<SP>2</SP> and R<SP>3</SP> are H or Cl, and the non-toxic, pharmaceutically acceptable salts thereof are prepared, in the case of compounds of Formula I, by acylating a compound of the general formula or a carboxylic acid salt thereof with an acid of the formula or an acylating derivative or mixed anhydride thereof, wherein -NXY is a protected amino group in which X is H and Y is t-butoxycarbonyl, benzyloxycarbonyl or 2,2,2-trichloroethoxy carbonyl or like protecting group or X and Y taken together represent a 2-hydroxy-lnaphthylmethylene group or a like protecting group in an inert solvent at a temperature below 0‹ C. and subsequently removing the protecting group; and then optionally forming a salt or reacting with acetone at a temperature of - 20‹ to 50‹ C. to give a compound of Formula II. The acylating acids of general Formula IV are prepared from the corresponding unprotected amines by known methods. The D-(-)-2- (p-hydroxyphenyl) glycine is prepared by the following series of reactions: (A) p-anisaldehyde + NaCN+NH 4 OH (E) The product of reaction (D) is heated with 48% HBr to yield the corresponding hydroxy compound. D - ( - ) - α - (p - hydroxyphenyl) - α - (t - butoxycarbonylamino) acetic acid is prepared by reacting a suspension of D-( - )-2-(p-hydroxyphenyl)- glycine and magnesium oxide, in dioxane-water, with t-butoxycarbonyl azide. The corresponding 3-chloro- and 3,5-dichloro-compounds are similarly prepared by using the appropriate chloro-substituted glycines as starting materials. The 3 - chloro- and 3,5 - dichloro - derivatives of D - ( - ) - 2 - (p - hydroxyphenyl) glycine are prepared by treating the hydrochloride of the glycine with one or two moles, respectively, of sulfuryl chloride in glacial acetic acid. D - ( - ) - α - carbobenzoxyamino - α - (4 - carbohenzoxyoxyphenyl) acetic acid is prepared by reacting D-( - )-2-(p-hydroxyphenyl) glycine with carbobenzoxychloride. Pharmaceutical compositions comprise a compound of Formula I or II and a carrier or diluent. The compositions, or active ingredients thereof, may be used to treat animals, including poultry.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2422385-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S57185291-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S49135989-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S4985002-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S5036485-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4160863-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4234721-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE31730-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S6043073-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4504657-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5003064-A
priorityDate 1967-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25200582
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10387
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455824799
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393647
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61256
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537453
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24648
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14792
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452419213
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11821572
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450926304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415729715
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419566245
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410925215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21886435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491805
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8929
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538728
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524795

Total number of triples: 53.